Mirae Asset Global Investments Co., Ltd. Lexicon Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 12,046 shares of LXRX stock, worth $8,793. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,046
Previous 13,074
7.86%
Holding current value
$8,793
Previous $20,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LXRX
# of Institutions
136Shares Held
238MCall Options Held
459KPut Options Held
133K-
Artal Group S.A. Luxembourg, N4136MShares$99.4 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$28.4 Million3.05% of portfolio
-
Orbimed Advisors LLC San Diego, CA11MShares$8.05 Million0.41% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.09MShares$5.91 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $138M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...